Cargando…
Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer
Background: Increased serum neuron-specific enolase (NSE) level was found in a substantial proportion (30–69%) of patients with non-small-cell lung cancer (NSCLC), but little was known about the clinical properties of NSE in NSCLC. Objective: We aimed to assess the level of serum NSE to predict prog...
Autores principales: | Yan, Peng, Han, Yiming, Tong, Anna, Liu, Jie, Wang, Xinyu, Liu, Chuanyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329647/ https://www.ncbi.nlm.nih.gov/pubmed/34286335 http://dx.doi.org/10.1042/BSR20210866 |
Ejemplares similares
-
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
por: Baudin, E., et al.
Publicado: (1998) -
Prognostic Value of Investigating Neuron-Specific Enolase in Patients with Ischemic Stroke
por: Kurakina, А.S., et al.
Publicado: (2021) -
Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis
por: Tian, Zhoujunyi, et al.
Publicado: (2020) -
Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis
por: Zhang, Jing, et al.
Publicado: (2020) -
Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer
por: Sun, Lin, et al.
Publicado: (2020)